Table 2 Kentucky hospital and emergency department substance use disorder services offered

Pharmacy

 Buprenorphine on hospital pharmacy’s formulary

67

79%

14

16%

4

5%

 Hospital has outpatient pharmacy with buprenorphine

33

39%

48

56%

4

5%

 ED has buprenorphine in Pixys medstation (n = 74)^a

28

38%

43

58%

3

4%

 ED has own pharmacy

6

7%

79

93%

0

0%

SUD Screening

 ED has screening protocol to identify patients with substance use disorder

37

44%

43

51%

5

6%

 Protocol built into EHR (n = 37)^b

36

97%

1

3%

0

0%

 Which patients are screened for SUD (n = 37)^b

  All

25

68%

-

-

-

-

  Some

11

30%

-

-

-

-

  None

1

3%

-

-

-

-

MOUD Prescribing

 ED has written protocol to prescribe buprenorphine to patients with OUD

9

11%

70

82%

6

7%

 ED facilitates home buprenorphine induction

2

2%

64

75%

19

22%

Approximate percentage of ED providers who prescribed buprenorphine in past 12 months

 None

48

56%

-

-

-

-

 1 − 25%

7

8%

-

-

-

-

 26 − 50%

2

2%

-

-

-

-

 51 − 75%

1

1%

-

-

-

-

 Over 75%

1

1%

-

-

-

-

 Do not know

26

31%

-

-

-

-

 Require counseling, behavioral health intervention to receive MOUD

7

8%

52

61%

26

31%

Peer supports and social services

 Hospital utilizes peer supports in ED for patients with SUD

11

13%

68

80%

6

7%

 ED has direct access to hospital and/or ED social workers for patients with substance use disorder

42

49%

37

44%

-

-

Harm reduction standard protocol services^c

 Overdose education

46

54%

-

-

-

-

 Safer use education

28

33%

-

-

-

-

 No harm reduction services provided

20

24%

-

-

-

-

 Take-home naloxone

20

24%

-

-

-

-

 Other (please specify)

10

12%

-

-

-

-

 Co-prescribing naloxone with opioid prescriptions

9

11%

-

-

-

-

 Safer use supplies such as fentanyl test strips

0

0%

-

-

-

-

 Wound care kit

0

0%

-

-

-

-